Nuo Therapeutics Announces Senior Management Change And Provides Limited Corporate Update

GAITHERSBURG, Md.--(BUSINESS WIRE)--Nuo Therapeutics, Inc. (OTCQX: NUOT) (“Nuo” or the “Company”), today announced that the Company has provided written notice to terminate, without cause, the employment relationship between the Company and Dean Tozer, its President and Chief Executive Officer. Also on January 8, 2016, the Board appointed the Company’s Acting Chief Financial Officer, David E. Jorden, as the Company's Acting Chief Executive Officer, effective immediately.